New clinical trial designs for establishing drug efficacy and safety in a precision medicine era
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New clinical trial designs for establishing drug efficacy and safety in a precision medicine era
Authors
Keywords
-
Journal
DIABETES OBESITY & METABOLISM
Volume 20, Issue -, Pages 14-18
Publisher
Wiley
Online
2018-10-08
DOI
10.1111/dom.13417
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy
- (2018) Hiddo J. L. Heerspink et al. DIABETES OBESITY & METABOLISM
- Baseline characteristics and enrichment results from the SONAR trial
- (2018) Hiddo J.L. Heerspink et al. DIABETES OBESITY & METABOLISM
- IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
- (2018) N.H. Cho et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy
- (2017) Jicheng Lv et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease
- (2017) Steven G. Coca et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both
- (2017) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
- (2017) Bruce Neal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Management of patients with diabetes and CKD: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
- (2016) Vlado Perkovic et al. KIDNEY INTERNATIONAL
- Adaptive Randomization of Neratinib in Early Breast Cancer
- (2016) John W. Park et al. NEW ENGLAND JOURNAL OF MEDICINE
- Worldwide access to treatment for end-stage kidney disease: a systematic review
- (2015) Thaminda Liyanage et al. LANCET
- Diabetic kidney disease
- (2015) Merlin C. Thomas et al. Nature Reviews Disease Primers
- Intensive glucose control improves kidney outcomes in patients with type 2 diabetes
- (2013) Vlado Perkovic et al. KIDNEY INTERNATIONAL
- Circulating TNF Receptors 1 and 2 Predict ESRD in Type 2 Diabetes
- (2012) M. A. Niewczas et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
- (2011) Colin Baigent et al. LANCET
- Enrichment of Clinical Study Populations
- (2010) R Temple CLINICAL PHARMACOLOGY & THERAPEUTICS
- Costs of dialysis--a regional population-based analysis
- (2009) A. Icks et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- ACE Gene Polymorphism and Losartan Treatment in Type 2 Diabetic Patients With Nephropathy
- (2008) H.-H. Parving et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
- (2008) NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started